Skip to main content
OpenTrials

Clinical trial condition

Disease Progression

Explore clinical trials studying Disease Progression. Study availability and eligibility vary by location and protocol.

281 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Disease Progression trial results

Recruiting

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

NCT04678648

Conditions
Advanced Malignant Solid Neoplasm, Astrocytoma, Colon Cancer, +35 more
Locations
  • University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon, SCRI Oncology Partners - Health One Denver, Colorado, United States
  • Sarah Cannon, SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details
Recruiting

Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET

NCT04954820

Conditions
Disease Attributes, Disease Progression, Intestinal Well Differentiated Endocrine Tumor, +9 more
Locations
  • Institut de Cancérologie de l'Ouest Site d'Angers Angers, France
  • Institut Bergonié Bordeaux, France
  • CHRU Morvan Brest, France
  • Hospices civils de LYON - GHE Bron, France
View all 28 locations
View Trial Details
Recruiting

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

NCT05297734

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +81 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of South Alabama Mobile, Alabama, United States
  • Beckman Research Institute of City of Hope Duarte, California, United States
  • VA Medical Center, Fresno Fresno, California, United States
View all 17 locations
View Trial Details
Recruiting

Combination of TATE and PD-1 Inhibitor in Liver Cancer

NCT03259867

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +18 more
Locations
  • University of California, Irvine Orange, California, United States
  • University of Oklahoma Health Science Center Oklahoma City, Oklahoma, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Recruiting

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

NCT05204017

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Disease Attributes, +16 more
Locations
  • University of Alberta Edmonton, Alberta, Canada
  • University of Toronto / Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
  • McGill University / Montreal Neurological Institute and Hospital Montreal, Quebec, Canada
  • CHU de Quebec -Universite de Laval Québec, Quebec, Canada
View Trial Details

Related conditions